查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1928612

医疗MCS设备市场按产品类型、技术、行动性、应用和最终用户划分，全球预测，2026-2032年

Medical MCS Device Market by Product Type, Technology, Mobility, Application, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 186 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2025 年，医疗 MCS 设备市场价值将达到 22.8 亿美元，到 2026 年将成长至 24.6 亿美元，到 2032 年将达到 38.2 亿美元，复合年增长率为 7.60%。

关键市场统计数据
基准年 2025 22.8亿美元
预计年份：2026年 24.6亿美元
预测年份 2032 38.2亿美元
复合年增长率 (%) 7.60%

对影响现代机械循环辅助装置应用的临床因素、技术进步、法规环境和相关人员责任进行重点分析

机械循环支援装置在先进心臟病学、重症监护和生物医学工程的交叉领域发挥核心作用。这项涵盖体外氧合平台、植入式心室辅助装置和全人工心臟的技术体系，旨在满足晚期心臟衰竭和急性心肺功能不全患者维持血流动力学稳定的迫切临床需求。临床决策越来越重视及时提供循环支持，以作为復健桥樑、移植桥樑、根治性治疗或安宁疗护的手段，而装置的选择则取决于疾病严重、患者生理状况和治疗环境。

循环支援领域正在经历技术、临床、监管和供应链变革的融合，这些变革正在重塑设备配置、数据整合和护理模式。

机械循环支持系统正经历变革性的转变，重新定义了设备设计、照护模式和商业策略。其中一个显着的变化是，大型固定式系统正稳步向更紧凑、更节能的平台过渡，从而实现长期门诊管理。泵浦技术和材料科学的进步进一步推动了这一趋势，降低了血栓形成风险并延长了设备的使用寿命。同时，连续流动动态和控制演算法的创新正在提高生理响应性，使其能够更好地适应患者的活动水平，从而改善患者的生活品质。

评估不断变化的关税政策对整个设备供应链的筹资策略、供应商多元化、製造本地化和采购韧性的影响

跨境关税和政策措施会改变贸易格局，对医疗设备製造商、供应商和医疗系统采购者产生可衡量的营运影响。关税调整实施后，采购团队和製造负责人必须重新评估零件采购、库存策略和供应商合同，以维持成本可控性和供应连续性。关税导致的投入成本变化主要促使企业采取两种策略因应措施：一是尽可能提高关键零件生产的在地化程度；二是实现供应商网路多元化，以降低单一来源风险。这两种应对措施都需要前期投资，用于寻找新的供应商、检验流程控制以及更新监管文件，以提供製造地和材料规格等资讯。

对设备设计、临床检验、服务模式和报销策略的影响因产品类型、应用、技术、最终用户和行动配置而异

我们对机械循环支援装置的市场结构进行了分析，并根据临床和商业性细分，揭示了不同产品类别、应用、技术、最终用户和移动方式所带来的独特需求驱动因素和营运重点。产品系列包括双心室辅助装置、植入式左心室和右心室辅助装置、体外膜氧合（ECMO）以及全人工心臟解决方案，每种产品在设计、植入和追踪方面都有其独特的要求。临床应用领域涵盖復健过渡（包括长期和短期）、移植过渡、合格移植患者的最终治疗以及安宁疗护，其主要目标是缓解症状并提高生活品质。技术选择（包括连续流配置，如轴流和离心流，以及脉动流系统）直接影响抗凝血策略、血流动力学特征和病患监测通讯协定。

区域法规结构、临床基础设施、报销机制和製造地对医疗器材采用和商业化策略的综合影响

区域趋势对监管路径、临床应用、製造地和报销模式有显着影响。在製定商业化和供应策略时，必须认真考虑这些差异。在美洲，成熟的三级医疗网路和高容量的移植中心对植入式心室辅助装置和先进的体外循环支援设备有着集中的需求。支付体系和医院资本规划实务影响着设备的生命週期管理以及对整体医疗成本的关注。在欧洲、中东和非洲地区，不同的法规环境和医院基础设施造成了不同的市场接受度曲线。虽然欧洲部分地区正在快速推广门诊和居家治疗项目，但中东和北非市场优先考虑可扩展的急性护理解决方案和医护人员队伍建设，以扩大服务覆盖范围。

我们在技术差异化、策略合作、证据产生和全面的售后服务方面拥有竞争优势，使我们能够获得临床和商业性优势。

机械循环支援领域的竞争格局呈现出多元化的特点，既有老牌医疗设备巨头，也有敏捷的专业创新者、学术型新创公司和契约製造，它们都在加速产品创新和服务差异化。主要企业专注于发展其核心技术平台，推动诸如具有优化血液相容性的驱动系统、紧凑型能量和温度控管解决方案以及支援远端监测和预测性维护的嵌入式感测器套件等技术。同时，规模较小的公司则倾向于专注于有望出现颠覆性创新的细分领域，例如全可穿戴式循环支援设备、用于减少血栓症形成的新型生物材料以及实现封闭回路型血流动力学控制的软体架构。

医疗设备领导者可采取切实可行的策略重点，整合临床证据、生产韧性、数位化能力和支付方合作，以实现持续应用。

为了赢得临床信赖和机构认可，产业领导者应采取一套协调一致的策略，将临床证据、生产韧性和商业性可行性结合。首先，投资于有针对性的临床研究和註册登记，以证明设备在与机构合作伙伴最相关的特定应用中的性能，涵盖从短期急性支持到长期临终关怀等各种场景。同时，加快人体工学测试和临床工作流程整合，以减轻训练负担，并最大限度地减少门诊和居家照护过渡期间的不利事件。其次，努力实现供应商多元化和区域化生产，以降低政策主导的成本波动和供应中断风险。尽可能推进二级供应商资格认证，并考虑策略性库存布局，以确保医疗服务的连续性。

一项全面且检验的研究途径整合了临床医生参与、系统性的二级文献综述、供应链分析以及交叉检验的分析方法，以确保研究结果的可靠性。

我们采用严谨的调查方法来分析机械循环支援技术，该方法结合了与关键相关人员的直接对话、系统的二手文献综述以及数据三角验证，以检验研究结果并识别挑战。主要研究包括对心臟外科医生、心臟科医生、重症循环系统技师和护理管理人员进行结构化访谈，以及与供应链经理、生物医学工程师和医院采购负责人进行讨论，以了解操作流程。二手研究整合了同行评审的临床文献、监管申报文件、临床试验註册资讯、医疗设备标籤和说明书以及相关监管机构发布的标准，以阐明产品功能和安全性方面的考虑。

整合临床、营运和商业性需求，制定切实可行的蓝图，指导医疗设备创新，进而为病患和医疗机构带来永续的成果。

机械循环支援领域正处于一个转折点，技术进步、不断演进的护理模式和政策趋势在此交汇，为相关人员带来机会和挑战。泵浦设计、远端监测和生物相容性材料的进步正在拓展设备的临床效用，并催生出传统重症监护环境之外的新型护理路径。同时，管理体制、采购行为和基础设施能力的区域差异要求制定个人化的商业化和部署策略。影响贸易和关税环境的政策变化进一步凸显了製造和采购弹性对于维持设备供应和成本效益的重要性。

目录

第一章：序言

第二章调查方法

  • 研究设计
  • 研究框架
  • 市场规模预测
  • 数据三角测量
  • 调查结果
  • 调查前提
  • 调查限制

第三章执行摘要

  • 首席体验长观点
  • 市场规模和成长趋势
  • 2025年市占率分析
  • FPNV定位矩阵，2025
  • 新的商机
  • 下一代经营模式
  • 产业蓝图

第四章 市场概览

  • 产业生态系与价值链分析
  • 波特五力分析
  • PESTEL 分析
  • 市场展望
  • 上市策略

第五章 市场洞察

  • 消费者洞察与终端用户观点
  • 消费者体验基准
  • 机会地图
  • 分销通路分析
  • 价格趋势分析
  • 监理合规和标准框架
  • ESG与永续性分析
  • 中断和风险情景
  • 投资报酬率和成本效益分析

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

第八章 依产品类型分類的医疗MCS设备市场

  • 双心室辅助装置
  • 体外膜氧合器
  • 左心室辅助装置
  • 右心辅助装置
  • 人工心臟

9. 按技术分類的医疗MCS设备市场

  • 连续流
    • 轴流式
    • 离心流
  • 脉动流

第十章：医疗MCS设备市场趋势

  • 携带式的
    • 嵌入式
    • 穿戴式装置
  • 固定式

第十一章 依应用分類的医疗MCS设备市场

  • 通往復健的桥樑
    • 长期
    • 短期
  • 移植桥樑
  • 最终治疗
  • 安宁疗护

第十二章 依最终使用者分類的医疗MCS设备市场

  • 门诊治疗中心
  • 居家医疗环境
  • 医院
    • 心臟监护病房
      • 成人加护病房
      • 儿童加护病房
    • 加护病房

第十三章 医疗MCS设备市场（依地区划分）

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十四章 医疗MCS设备市场（依类别划分）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十五章 各国医疗MCS设备市场

  • 我们
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十六章：美国医疗MCS设备市场

第十七章：中国医疗MCS设备市场

第十八章 竞争格局

  • 市场集中度分析，2025年
    • 浓度比（CR）
    • 赫芬达尔-赫希曼指数 (HHI)
  • 近期趋势及影响分析，2025 年
  • 2025年产品系列分析
  • 基准分析，2025 年
  • Abbott Laboratories
  • Abiomed, Inc.
  • Alcon, Inc.
  • B. Braun Melsungen AG
  • Baxter International Inc.
  • Becton, Dickinson and Company
  • Berlin Heart GmbH
  • Boston Scientific Corporation
  • Edwards Lifesciences Corporation
  • Fresenius Medical Care AG & Co. KGaA
  • GE HealthCare
  • Getinge AB
  • Intuitive Surgical, Inc.
  • Johnson & Johnson
  • Koninklijke Philips NV
  • LivaNova PLC
  • Medtronic plc
  • Nipro Corporation
  • Siemens Healthineers AG
  • Stryker Corporation
  • SynCardia Systems, LLC
  • Terumo Corporation
  • Zimmer Biomet Holdings, Inc.
  • ZOLL Medical Corporation
Product Code: MRR-92740D85F068

The Medical MCS Device Market was valued at USD 2.28 billion in 2025 and is projected to grow to USD 2.46 billion in 2026, with a CAGR of 7.60%, reaching USD 3.82 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 2.28 billion
Estimated Year [2026] USD 2.46 billion
Forecast Year [2032] USD 3.82 billion
CAGR (%) 7.60%

A focused orientation to the clinical drivers, technological progress, regulatory context, and stakeholder responsibilities shaping modern mechanical circulatory support device adoption

Mechanical circulatory support devices occupy a central role at the intersection of advanced cardiology, critical care, and biomedical engineering. This body of technologies - spanning extracorporeal oxygenation platforms, implantable ventricular assist devices, and fully artificial hearts - responds to an urgent clinical imperative: sustaining hemodynamic stability in patients with advanced heart failure and acute cardiopulmonary collapse. Clinical decision pathways increasingly prioritize timely circulatory support as a bridge to recovery, a bridge to transplantation, destination therapy, or palliative relief, and the choice of device is governed by acuity, patient physiology, and care setting.

Against this clinical backdrop, manufacturers and health systems are navigating converging trends in miniaturization, biocompatible materials, power management, and control software. These developments are reshaping device usability and expanding opportunities for ambulatory and home-based management. Simultaneously, evolving regulatory expectations and the maturation of post-market surveillance demand more robust real-world evidence and human factors validation. As a result, stakeholders from clinicians and device engineers to procurement officers and payers must align clinical evidence strategies, training pathways, and service models to ensure safe, effective, and sustainable adoption. The following analysis synthesizes these dynamics, articulates pivotal shifts in the landscape, and frames actionable priorities for clinical and commercial leadership.

Key technological, clinical, regulatory, and supply chain transformations converging to reshape device form factors, data integration, and care models in circulatory support

The mechanical circulatory support ecosystem is undergoing transformative shifts that are redefining device design, care delivery models, and commercial strategies. A prominent change is the steady move from large, stationary systems toward more compact, energy-efficient platforms enabling longer-term outpatient management. This trend is reinforced by advances in pump technology and materials science that reduce thrombogenicity and extend device longevity. Concurrently, innovations in continuous flow dynamics, and control algorithms have enhanced physiological responsiveness, enabling smoother integration with patient activity levels and improving quality-of-life outcomes.

Another critical evolution is the integration of digital health capabilities: embedded sensors, remote telemetry, and predictive analytics are beginning to inform clinical decision-making and proactive device management. These capabilities support earlier detection of complications, reduce readmissions, and create new service layers around remote monitoring and algorithm-driven alerts. Regulatory pathways have adapted in parallel, with an increased focus on post-market data and clinical registries that validate real-world performance. Supply chains and manufacturing models are also shifting; there is greater emphasis on regional sourcing, modular production, and robust quality systems that can scale rapidly in response to demand fluctuations. Together, these shifts are raising the bar for clinical evidence, interoperability, and lifecycle services, prompting manufacturers and providers to rethink product roadmaps, reimbursement discussions, and long-term patient support strategies.

Assessment of how evolving tariff policies influence sourcing strategies, supplier diversification, manufacturing localization, and procurement resilience across device supply chains

Policy actions that alter cross-border tariffs and trade dynamics introduce measurable operational effects for device manufacturers, suppliers, and health system purchasers. When tariff adjustments are introduced, procurement teams and manufacturing leaders must reassess component sourcing, inventory strategies, and supplier contracts to preserve affordability and supply continuity. Tariff-driven input cost changes tend to prompt two strategic responses: increased localization of critical component production where feasible, and the diversification of supplier networks to mitigate single-source risk. Both responses require upfront investment in qualifying new vendors, validating process controls, and updating regulatory filings that reference manufacturing sites and material specifications.

Hospitals and integrated health systems that operate constrained capital budgets may react to cost pressures by extending device lifecycles through more rigorous maintenance and reuse protocols where clinically appropriate, or by prioritizing devices with lower total cost of care implications. Clinical trial sponsors and investigators may also confront higher operational expenses for imported specialized equipment, influencing site selection and study timelines. From a commercial standpoint, companies are likely to revisit pricing strategies, service contract structures, and the geographic allocation of inventory to optimize duty exposure. Importantly, tariff shifts often accelerate conversations about regional manufacturing hubs and contract manufacturing relationships, as these arrangements can reduce exposure to import duties and shorten lead times. To preserve patient access and clinical continuity, stakeholders must adopt nimble sourcing, transparent cost modeling, and collaborative procurement frameworks that accommodate policy variability while safeguarding quality and safety standards.

Segment-driven implications for device engineering, clinical validation, service models, and reimbursement strategies across product types, applications, technologies, end users, and mobility configurations

Decomposing the mechanical circulatory support landscape through clinical and commercial segmentation reveals differentiated demand drivers and operational priorities across product classes, applications, technologies, end users, and mobility profiles. Product portfolios span devices designed for biventricular support, implantable left ventricular assist devices, right ventricular assist devices, extracorporeal membrane oxygenation systems, and total artificial heart solutions, each with distinct engineering, implantation, and follow-up requirements. Clinical applications encompass the bridge to recovery pathway in both long-term and short-term contexts, bridge to transplant, destination therapy for patients ineligible for transplant, and palliative care where symptom relief and quality of life are the primary objectives. The choice of technology-between continuous flow configurations, which include axial flow and centrifugal flow variants, and pulsatile flow systems-directly affects anticoagulation strategies, hemodynamic profiles, and patient monitoring protocols.

End-user environments shape usability and service needs; ambulatory care centers and home care settings demand simplified interfaces, remote monitoring, and compact power systems to facilitate patient mobility, whereas hospital deployments concentrate in cardiac care units and intensive care units, with cardiac care further divided into adult and pediatric intensive care contexts that have specific size, hemodynamic, and training considerations. Mobility preferences bifurcate into portable and stationary offerings, with portable devices further categorized into implantable and wearable forms that influence battery technology, human factors design, and maintenance workflows. Recognizing these segment-level distinctions enables manufacturers to prioritize clinical evidence generation tailored to use cases, design service models that match end-user capabilities, and align reimbursement narratives with the operational realities of selected care settings and technologies.

How regional regulatory frameworks, clinical infrastructure, reimbursement mechanisms, and manufacturing footprints collectively influence device adoption and commercialization tactics

Regional dynamics exert a powerful influence on regulatory pathways, clinical adoption, manufacturing footprints, and reimbursement models, and these differences merit careful consideration when planning commercialization and supply strategies. In the Americas, mature tertiary care networks and high-volume transplant centers create concentrated demand for implantable ventricular assist systems and advanced extracorporeal support. Payment systems and hospital capital planning practices influence device lifecycle management and the emphasis placed on total cost of care. In Europe, Middle East & Africa, heterogeneous regulatory environments and variable hospital infrastructure drive divergent adoption curves; parts of Europe demonstrate rapid uptake of ambulatory and home-based programs, while markets in the Middle East and Africa prioritize scalable acute care solutions and workforce training to expand access.

Across Asia-Pacific, rapid investment in specialized cardiac centers, expanding middle-class patient populations, and proximity to manufacturing hubs stimulate both domestic innovation and regional production partnerships. Telemedicine penetration and home-care capabilities are rising across several Asia-Pacific markets, enabling earlier discharge models and remote follow-up services. Importantly, regional tariff regimes and trade agreements further shape where manufacturers locate production and how they price devices to maintain competitive access. Understanding these regional nuances allows clinical leaders and commercial teams to tailor evidence generation, field service models, and partner selection to local regulatory expectations, reimbursement mechanisms, and care delivery practices.

Competitive dynamics that prioritize technological differentiation, strategic partnerships, evidence generation, and comprehensive aftermarket services to secure clinical and commercial advantage

Competitive dynamics in the mechanical circulatory support arena are defined by a mix of established medical device incumbents, agile specialty innovators, academic spinouts, and contract manufacturers that together accelerate product innovation and service differentiation. Leading organizations focus on advancing core technology enablers-drive systems with optimized hemocompatibility profiles, compact energy and thermal management solutions, and embedded sensor suites that support remote monitoring and predictive maintenance. At the same time, smaller and mid-stage companies often concentrate on disruptive niches such as fully wearable circulatory assist devices, novel biomaterials to reduce thrombosis, or software architectures that facilitate closed-loop hemodynamic control.

Strategic collaboration is increasingly common: partnerships with clinical networks accelerate real-world evidence collection, alliances with contract manufacturers support scalable production, and cooperation with software firms enhances data analytics and interoperability. Aftermarket services and training programs have emerged as differentiators, with comprehensive clinician education, rapid-response field engineering, and remote telemetry services improving patient outcomes and device uptime. For commercial leaders, prioritizing differentiated clinical value propositions, investing in evidence generation to substantiate safety and usability claims, and building resilient supply and service networks are central to maintaining a competitive edge in a technology-driven landscape.

Actionable strategic priorities for medical device leaders to align clinical evidence, manufacturing resilience, digital capabilities, and payer engagement for sustainable adoption

Industry leaders should pursue a coordinated set of strategies that align clinical evidence, manufacturing resilience, and commercial execution to capture clinical trust and institutional adoption. First, invest in targeted clinical studies and registry participation that demonstrate device performance across the specific applications most relevant to institutional partners, including both short-term acute support and longer-term destination therapy scenarios. Concurrently, accelerate human factors testing and clinician workflow integration to reduce training burdens and minimize adverse events during transition to ambulatory or home-based care. Second, strengthen supplier diversification and regional manufacturing relationships to reduce exposure to policy-driven cost shifts and supply disruptions; where possible, qualify secondary vendors and consider strategic inventory positioning to preserve continuity of care.

Third, develop tiered service and reimbursement narratives that quantify reductions in readmission, improvement in functional status, and the value of remote monitoring for early complication detection, enabling productive discussions with payers and hospital procurement teams. Fourth, prioritize digital capabilities by embedding telemetry and analytics that support predictive maintenance and clinical decision support, while ensuring robust cybersecurity and data governance. Finally, pursue collaborative models with health systems, academic centers, and payers that spread implementation risk, facilitate evidence generation, and create repeatable deployment pathways. By integrating these actions, leaders can align product design, evidence development, and commercial models to the operational realities of contemporary cardiac care.

A comprehensive, validated research approach combining primary clinician engagement, systematic secondary review, supply chain mapping, and cross-validated analytical techniques to ensure robust insights

A rigorous research methodology for analyzing mechanical circulatory support technologies blends primary stakeholder engagement, systematic secondary review, and data triangulation to validate findings and identify gaps. Primary research includes structured interviews with clinicians across cardiac surgery, cardiology, critical care, perfusionists, and nursing leadership, along with discussions with supply chain managers, biomedical engineers, and hospital procurement officers to capture operational realities. Secondary research synthesizes peer-reviewed clinical literature, regulatory filings, clinical trial registries, device labeling and instructions for use, and standards issued by relevant regulatory authorities to contextualize product capabilities and safety considerations.

Analytical approaches incorporate comparative technology assessments, lifecycle and service model analysis, and supply chain mapping that traces critical component origins and potential single-point vulnerabilities. Triangulation of qualitative insights and technical documentation ensures robustness, while scenario analysis explores implications of policy shifts, reimbursement changes, and technological breakthroughs. Quality controls include cross-validation of key findings with multiple expert sources and iterative review cycles with clinical advisors to ensure clinical and operational accuracy. This methodology balances depth with practical relevance, providing stakeholders with evidence-based insights that support strategic decision-making and operational planning.

Synthesis of clinical, operational, and commercial imperatives that define a practical roadmap for translating device innovation into durable patient and institutional outcomes

The mechanical circulatory support landscape is at an inflection point where technological progress, evolving care models, and policy dynamics intersect to create both opportunity and complexity for stakeholders. Advances in pump design, remote monitoring, and biocompatible materials are expanding the clinical utility of devices and enabling new care pathways outside traditional intensive care settings. At the same time, regional diversity in regulatory regimes, procurement behaviors, and infrastructure capacity requires tailored commercialization and deployment strategies. Policy changes that influence trade and tariff environments further underline the need for manufacturing and procurement agility to maintain device availability and cost-effectiveness.

For clinicians, manufacturers, and health system leaders, the path forward rests on aligning robust clinical evidence with service models that support safe, scalable adoption. Investments in human factors, clinician training, and remote monitoring capabilities will determine how quickly ambulatory and home-based models can be implemented without compromising patient safety. Simultaneously, commercial success will hinge on resilient supply chains, targeted regional strategies, and collaborative partnerships that accelerate evidence generation and reimbursement acceptance. In sum, stakeholders who proactively integrate clinical, operational, and commercial planning will be best positioned to translate technological potential into sustained patient benefit and institutional value.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Medical MCS Device Market, by Product Type

  • 8.1. Biventricular Assist Device
  • 8.2. Extracorporeal Membrane Oxygenation
  • 8.3. Left Ventricular Assist Device
  • 8.4. Right Ventricular Assist Device
  • 8.5. Total Artificial Heart

9. Medical MCS Device Market, by Technology

  • 9.1. Continuous Flow
    • 9.1.1. Axial Flow
    • 9.1.2. Centrifugal Flow
  • 9.2. Pulsatile Flow

10. Medical MCS Device Market, by Mobility

  • 10.1. Portable
    • 10.1.1. Implantable
    • 10.1.2. Wearable
  • 10.2. Stationary

11. Medical MCS Device Market, by Application

  • 11.1. Bridge To Recovery
    • 11.1.1. Long-Term
    • 11.1.2. Short-Term
  • 11.2. Bridge To Transplant
  • 11.3. Destination Therapy
  • 11.4. Palliative Care

12. Medical MCS Device Market, by End User

  • 12.1. Ambulatory Care Centers
  • 12.2. Home Care Settings
  • 12.3. Hospitals
    • 12.3.1. Cardiac Care Units
      • 12.3.1.1. Adult ICU
      • 12.3.1.2. Pediatric ICU
    • 12.3.2. Intensive Care Units

13. Medical MCS Device Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Medical MCS Device Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Medical MCS Device Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. United States Medical MCS Device Market

17. China Medical MCS Device Market

18. Competitive Landscape

  • 18.1. Market Concentration Analysis, 2025
    • 18.1.1. Concentration Ratio (CR)
    • 18.1.2. Herfindahl Hirschman Index (HHI)
  • 18.2. Recent Developments & Impact Analysis, 2025
  • 18.3. Product Portfolio Analysis, 2025
  • 18.4. Benchmarking Analysis, 2025
  • 18.5. Abbott Laboratories
  • 18.6. Abiomed, Inc.
  • 18.7. Alcon, Inc.
  • 18.8. B. Braun Melsungen AG
  • 18.9. Baxter International Inc.
  • 18.10. Becton, Dickinson and Company
  • 18.11. Berlin Heart GmbH
  • 18.12. Boston Scientific Corporation
  • 18.13. Edwards Lifesciences Corporation
  • 18.14. Fresenius Medical Care AG & Co. KGaA
  • 18.15. GE HealthCare
  • 18.16. Getinge AB
  • 18.17. Intuitive Surgical, Inc.
  • 18.18. Johnson & Johnson
  • 18.19. Koninklijke Philips N.V.
  • 18.20. LivaNova PLC
  • 18.21. Medtronic plc
  • 18.22. Nipro Corporation
  • 18.23. Siemens Healthineers AG
  • 18.24. Stryker Corporation
  • 18.25. SynCardia Systems, LLC
  • 18.26. Terumo Corporation
  • 18.27. Zimmer Biomet Holdings, Inc.
  • 18.28. ZOLL Medical Corporation

LIST OF FIGURES

  • FIGURE 1. GLOBAL MEDICAL MCS DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL MEDICAL MCS DEVICE MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL MEDICAL MCS DEVICE MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL MEDICAL MCS DEVICE MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL MEDICAL MCS DEVICE MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL MEDICAL MCS DEVICE MARKET SIZE, BY MOBILITY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL MEDICAL MCS DEVICE MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL MEDICAL MCS DEVICE MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL MEDICAL MCS DEVICE MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL MEDICAL MCS DEVICE MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL MEDICAL MCS DEVICE MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. UNITED STATES MEDICAL MCS DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 13. CHINA MEDICAL MCS DEVICE MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL MEDICAL MCS DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL MEDICAL MCS DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL MEDICAL MCS DEVICE MARKET SIZE, BY BIVENTRICULAR ASSIST DEVICE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL MEDICAL MCS DEVICE MARKET SIZE, BY BIVENTRICULAR ASSIST DEVICE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL MEDICAL MCS DEVICE MARKET SIZE, BY BIVENTRICULAR ASSIST DEVICE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL MEDICAL MCS DEVICE MARKET SIZE, BY EXTRACORPOREAL MEMBRANE OXYGENATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL MEDICAL MCS DEVICE MARKET SIZE, BY EXTRACORPOREAL MEMBRANE OXYGENATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL MEDICAL MCS DEVICE MARKET SIZE, BY EXTRACORPOREAL MEMBRANE OXYGENATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL MEDICAL MCS DEVICE MARKET SIZE, BY LEFT VENTRICULAR ASSIST DEVICE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL MEDICAL MCS DEVICE MARKET SIZE, BY LEFT VENTRICULAR ASSIST DEVICE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL MEDICAL MCS DEVICE MARKET SIZE, BY LEFT VENTRICULAR ASSIST DEVICE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL MEDICAL MCS DEVICE MARKET SIZE, BY RIGHT VENTRICULAR ASSIST DEVICE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL MEDICAL MCS DEVICE MARKET SIZE, BY RIGHT VENTRICULAR ASSIST DEVICE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL MEDICAL MCS DEVICE MARKET SIZE, BY RIGHT VENTRICULAR ASSIST DEVICE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL MEDICAL MCS DEVICE MARKET SIZE, BY TOTAL ARTIFICIAL HEART, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL MEDICAL MCS DEVICE MARKET SIZE, BY TOTAL ARTIFICIAL HEART, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL MEDICAL MCS DEVICE MARKET SIZE, BY TOTAL ARTIFICIAL HEART, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL MEDICAL MCS DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL MEDICAL MCS DEVICE MARKET SIZE, BY CONTINUOUS FLOW, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL MEDICAL MCS DEVICE MARKET SIZE, BY CONTINUOUS FLOW, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL MEDICAL MCS DEVICE MARKET SIZE, BY CONTINUOUS FLOW, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL MEDICAL MCS DEVICE MARKET SIZE, BY CONTINUOUS FLOW, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL MEDICAL MCS DEVICE MARKET SIZE, BY AXIAL FLOW, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL MEDICAL MCS DEVICE MARKET SIZE, BY AXIAL FLOW, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL MEDICAL MCS DEVICE MARKET SIZE, BY AXIAL FLOW, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL MEDICAL MCS DEVICE MARKET SIZE, BY CENTRIFUGAL FLOW, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL MEDICAL MCS DEVICE MARKET SIZE, BY CENTRIFUGAL FLOW, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL MEDICAL MCS DEVICE MARKET SIZE, BY CENTRIFUGAL FLOW, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL MEDICAL MCS DEVICE MARKET SIZE, BY PULSATILE FLOW, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL MEDICAL MCS DEVICE MARKET SIZE, BY PULSATILE FLOW, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL MEDICAL MCS DEVICE MARKET SIZE, BY PULSATILE FLOW, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL MEDICAL MCS DEVICE MARKET SIZE, BY MOBILITY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL MEDICAL MCS DEVICE MARKET SIZE, BY PORTABLE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL MEDICAL MCS DEVICE MARKET SIZE, BY PORTABLE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL MEDICAL MCS DEVICE MARKET SIZE, BY PORTABLE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL MEDICAL MCS DEVICE MARKET SIZE, BY PORTABLE, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL MEDICAL MCS DEVICE MARKET SIZE, BY IMPLANTABLE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL MEDICAL MCS DEVICE MARKET SIZE, BY IMPLANTABLE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL MEDICAL MCS DEVICE MARKET SIZE, BY IMPLANTABLE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL MEDICAL MCS DEVICE MARKET SIZE, BY WEARABLE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL MEDICAL MCS DEVICE MARKET SIZE, BY WEARABLE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL MEDICAL MCS DEVICE MARKET SIZE, BY WEARABLE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL MEDICAL MCS DEVICE MARKET SIZE, BY STATIONARY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL MEDICAL MCS DEVICE MARKET SIZE, BY STATIONARY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL MEDICAL MCS DEVICE MARKET SIZE, BY STATIONARY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL MEDICAL MCS DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL MEDICAL MCS DEVICE MARKET SIZE, BY BRIDGE TO RECOVERY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL MEDICAL MCS DEVICE MARKET SIZE, BY BRIDGE TO RECOVERY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL MEDICAL MCS DEVICE MARKET SIZE, BY BRIDGE TO RECOVERY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL MEDICAL MCS DEVICE MARKET SIZE, BY BRIDGE TO RECOVERY, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL MEDICAL MCS DEVICE MARKET SIZE, BY LONG-TERM, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL MEDICAL MCS DEVICE MARKET SIZE, BY LONG-TERM, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL MEDICAL MCS DEVICE MARKET SIZE, BY LONG-TERM, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL MEDICAL MCS DEVICE MARKET SIZE, BY SHORT-TERM, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL MEDICAL MCS DEVICE MARKET SIZE, BY SHORT-TERM, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL MEDICAL MCS DEVICE MARKET SIZE, BY SHORT-TERM, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL MEDICAL MCS DEVICE MARKET SIZE, BY BRIDGE TO TRANSPLANT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL MEDICAL MCS DEVICE MARKET SIZE, BY BRIDGE TO TRANSPLANT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL MEDICAL MCS DEVICE MARKET SIZE, BY BRIDGE TO TRANSPLANT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL MEDICAL MCS DEVICE MARKET SIZE, BY DESTINATION THERAPY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL MEDICAL MCS DEVICE MARKET SIZE, BY DESTINATION THERAPY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL MEDICAL MCS DEVICE MARKET SIZE, BY DESTINATION THERAPY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL MEDICAL MCS DEVICE MARKET SIZE, BY PALLIATIVE CARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL MEDICAL MCS DEVICE MARKET SIZE, BY PALLIATIVE CARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL MEDICAL MCS DEVICE MARKET SIZE, BY PALLIATIVE CARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL MEDICAL MCS DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL MEDICAL MCS DEVICE MARKET SIZE, BY AMBULATORY CARE CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL MEDICAL MCS DEVICE MARKET SIZE, BY AMBULATORY CARE CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL MEDICAL MCS DEVICE MARKET SIZE, BY AMBULATORY CARE CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL MEDICAL MCS DEVICE MARKET SIZE, BY HOME CARE SETTINGS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL MEDICAL MCS DEVICE MARKET SIZE, BY HOME CARE SETTINGS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL MEDICAL MCS DEVICE MARKET SIZE, BY HOME CARE SETTINGS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL MEDICAL MCS DEVICE MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL MEDICAL MCS DEVICE MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL MEDICAL MCS DEVICE MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL MEDICAL MCS DEVICE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL MEDICAL MCS DEVICE MARKET SIZE, BY CARDIAC CARE UNITS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL MEDICAL MCS DEVICE MARKET SIZE, BY CARDIAC CARE UNITS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL MEDICAL MCS DEVICE MARKET SIZE, BY CARDIAC CARE UNITS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL MEDICAL MCS DEVICE MARKET SIZE, BY CARDIAC CARE UNITS, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL MEDICAL MCS DEVICE MARKET SIZE, BY ADULT ICU, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL MEDICAL MCS DEVICE MARKET SIZE, BY ADULT ICU, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL MEDICAL MCS DEVICE MARKET SIZE, BY ADULT ICU, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL MEDICAL MCS DEVICE MARKET SIZE, BY PEDIATRIC ICU, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL MEDICAL MCS DEVICE MARKET SIZE, BY PEDIATRIC ICU, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL MEDICAL MCS DEVICE MARKET SIZE, BY PEDIATRIC ICU, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL MEDICAL MCS DEVICE MARKET SIZE, BY INTENSIVE CARE UNITS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL MEDICAL MCS DEVICE MARKET SIZE, BY INTENSIVE CARE UNITS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL MEDICAL MCS DEVICE MARKET SIZE, BY INTENSIVE CARE UNITS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL MEDICAL MCS DEVICE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 91. AMERICAS MEDICAL MCS DEVICE MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 92. AMERICAS MEDICAL MCS DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 93. AMERICAS MEDICAL MCS DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 94. AMERICAS MEDICAL MCS DEVICE MARKET SIZE, BY CONTINUOUS FLOW, 2018-2032 (USD MILLION)
  • TABLE 95. AMERICAS MEDICAL MCS DEVICE MARKET SIZE, BY MOBILITY, 2018-2032 (USD MILLION)
  • TABLE 96. AMERICAS MEDICAL MCS DEVICE MARKET SIZE, BY PORTABLE, 2018-2032 (USD MILLION)
  • TABLE 97. AMERICAS MEDICAL MCS DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 98. AMERICAS MEDICAL MCS DEVICE MARKET SIZE, BY BRIDGE TO RECOVERY, 2018-2032 (USD MILLION)
  • TABLE 99. AMERICAS MEDICAL MCS DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 100. AMERICAS MEDICAL MCS DEVICE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 101. AMERICAS MEDICAL MCS DEVICE MARKET SIZE, BY CARDIAC CARE UNITS, 2018-2032 (USD MILLION)
  • TABLE 102. NORTH AMERICA MEDICAL MCS DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 103. NORTH AMERICA MEDICAL MCS DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 104. NORTH AMERICA MEDICAL MCS DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 105. NORTH AMERICA MEDICAL MCS DEVICE MARKET SIZE, BY CONTINUOUS FLOW, 2018-2032 (USD MILLION)
  • TABLE 106. NORTH AMERICA MEDICAL MCS DEVICE MARKET SIZE, BY MOBILITY, 2018-2032 (USD MILLION)
  • TABLE 107. NORTH AMERICA MEDICAL MCS DEVICE MARKET SIZE, BY PORTABLE, 2018-2032 (USD MILLION)
  • TABLE 108. NORTH AMERICA MEDICAL MCS DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 109. NORTH AMERICA MEDICAL MCS DEVICE MARKET SIZE, BY BRIDGE TO RECOVERY, 2018-2032 (USD MILLION)
  • TABLE 110. NORTH AMERICA MEDICAL MCS DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 111. NORTH AMERICA MEDICAL MCS DEVICE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 112. NORTH AMERICA MEDICAL MCS DEVICE MARKET SIZE, BY CARDIAC CARE UNITS, 2018-2032 (USD MILLION)
  • TABLE 113. LATIN AMERICA MEDICAL MCS DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 114. LATIN AMERICA MEDICAL MCS DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 115. LATIN AMERICA MEDICAL MCS DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 116. LATIN AMERICA MEDICAL MCS DEVICE MARKET SIZE, BY CONTINUOUS FLOW, 2018-2032 (USD MILLION)
  • TABLE 117. LATIN AMERICA MEDICAL MCS DEVICE MARKET SIZE, BY MOBILITY, 2018-2032 (USD MILLION)
  • TABLE 118. LATIN AMERICA MEDICAL MCS DEVICE MARKET SIZE, BY PORTABLE, 2018-2032 (USD MILLION)
  • TABLE 119. LATIN AMERICA MEDICAL MCS DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 120. LATIN AMERICA MEDICAL MCS DEVICE MARKET SIZE, BY BRIDGE TO RECOVERY, 2018-2032 (USD MILLION)
  • TABLE 121. LATIN AMERICA MEDICAL MCS DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 122. LATIN AMERICA MEDICAL MCS DEVICE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 123. LATIN AMERICA MEDICAL MCS DEVICE MARKET SIZE, BY CARDIAC CARE UNITS, 2018-2032 (USD MILLION)
  • TABLE 124. EUROPE, MIDDLE EAST & AFRICA MEDICAL MCS DEVICE MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 125. EUROPE, MIDDLE EAST & AFRICA MEDICAL MCS DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 126. EUROPE, MIDDLE EAST & AFRICA MEDICAL MCS DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 127. EUROPE, MIDDLE EAST & AFRICA MEDICAL MCS DEVICE MARKET SIZE, BY CONTINUOUS FLOW, 2018-2032 (USD MILLION)
  • TABLE 128. EUROPE, MIDDLE EAST & AFRICA MEDICAL MCS DEVICE MARKET SIZE, BY MOBILITY, 2018-2032 (USD MILLION)
  • TABLE 129. EUROPE, MIDDLE EAST & AFRICA MEDICAL MCS DEVICE MARKET SIZE, BY PORTABLE, 2018-2032 (USD MILLION)
  • TABLE 130. EUROPE, MIDDLE EAST & AFRICA MEDICAL MCS DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 131. EUROPE, MIDDLE EAST & AFRICA MEDICAL MCS DEVICE MARKET SIZE, BY BRIDGE TO RECOVERY, 2018-2032 (USD MILLION)
  • TABLE 132. EUROPE, MIDDLE EAST & AFRICA MEDICAL MCS DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 133. EUROPE, MIDDLE EAST & AFRICA MEDICAL MCS DEVICE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 134. EUROPE, MIDDLE EAST & AFRICA MEDICAL MCS DEVICE MARKET SIZE, BY CARDIAC CARE UNITS, 2018-2032 (USD MILLION)
  • TABLE 135. EUROPE MEDICAL MCS DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 136. EUROPE MEDICAL MCS DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 137. EUROPE MEDICAL MCS DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 138. EUROPE MEDICAL MCS DEVICE MARKET SIZE, BY CONTINUOUS FLOW, 2018-2032 (USD MILLION)
  • TABLE 139. EUROPE MEDICAL MCS DEVICE MARKET SIZE, BY MOBILITY, 2018-2032 (USD MILLION)
  • TABLE 140. EUROPE MEDICAL MCS DEVICE MARKET SIZE, BY PORTABLE, 2018-2032 (USD MILLION)
  • TABLE 141. EUROPE MEDICAL MCS DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 142. EUROPE MEDICAL MCS DEVICE MARKET SIZE, BY BRIDGE TO RECOVERY, 2018-2032 (USD MILLION)
  • TABLE 143. EUROPE MEDICAL MCS DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 144. EUROPE MEDICAL MCS DEVICE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 145. EUROPE MEDICAL MCS DEVICE MARKET SIZE, BY CARDIAC CARE UNITS, 2018-2032 (USD MILLION)
  • TABLE 146. MIDDLE EAST MEDICAL MCS DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 147. MIDDLE EAST MEDICAL MCS DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 148. MIDDLE EAST MEDICAL MCS DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 149. MIDDLE EAST MEDICAL MCS DEVICE MARKET SIZE, BY CONTINUOUS FLOW, 2018-2032 (USD MILLION)
  • TABLE 150. MIDDLE EAST MEDICAL MCS DEVICE MARKET SIZE, BY MOBILITY, 2018-2032 (USD MILLION)
  • TABLE 151. MIDDLE EAST MEDICAL MCS DEVICE MARKET SIZE, BY PORTABLE, 2018-2032 (USD MILLION)
  • TABLE 152. MIDDLE EAST MEDICAL MCS DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 153. MIDDLE EAST MEDICAL MCS DEVICE MARKET SIZE, BY BRIDGE TO RECOVERY, 2018-2032 (USD MILLION)
  • TABLE 154. MIDDLE EAST MEDICAL MCS DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 155. MIDDLE EAST MEDICAL MCS DEVICE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 156. MIDDLE EAST MEDICAL MCS DEVICE MARKET SIZE, BY CARDIAC CARE UNITS, 2018-2032 (USD MILLION)
  • TABLE 157. AFRICA MEDICAL MCS DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 158. AFRICA MEDICAL MCS DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 159. AFRICA MEDICAL MCS DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 160. AFRICA MEDICAL MCS DEVICE MARKET SIZE, BY CONTINUOUS FLOW, 2018-2032 (USD MILLION)
  • TABLE 161. AFRICA MEDICAL MCS DEVICE MARKET SIZE, BY MOBILITY, 2018-2032 (USD MILLION)
  • TABLE 162. AFRICA MEDICAL MCS DEVICE MARKET SIZE, BY PORTABLE, 2018-2032 (USD MILLION)
  • TABLE 163. AFRICA MEDICAL MCS DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 164. AFRICA MEDICAL MCS DEVICE MARKET SIZE, BY BRIDGE TO RECOVERY, 2018-2032 (USD MILLION)
  • TABLE 165. AFRICA MEDICAL MCS DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 166. AFRICA MEDICAL MCS DEVICE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 167. AFRICA MEDICAL MCS DEVICE MARKET SIZE, BY CARDIAC CARE UNITS, 2018-2032 (USD MILLION)
  • TABLE 168. ASIA-PACIFIC MEDICAL MCS DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 169. ASIA-PACIFIC MEDICAL MCS DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 170. ASIA-PACIFIC MEDICAL MCS DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 171. ASIA-PACIFIC MEDICAL MCS DEVICE MARKET SIZE, BY CONTINUOUS FLOW, 2018-2032 (USD MILLION)
  • TABLE 172. ASIA-PACIFIC MEDICAL MCS DEVICE MARKET SIZE, BY MOBILITY, 2018-2032 (USD MILLION)
  • TABLE 173. ASIA-PACIFIC MEDICAL MCS DEVICE MARKET SIZE, BY PORTABLE, 2018-2032 (USD MILLION)
  • TABLE 174. ASIA-PACIFIC MEDICAL MCS DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 175. ASIA-PACIFIC MEDICAL MCS DEVICE MARKET SIZE, BY BRIDGE TO RECOVERY, 2018-2032 (USD MILLION)
  • TABLE 176. ASIA-PACIFIC MEDICAL MCS DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 177. ASIA-PACIFIC MEDICAL MCS DEVICE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 178. ASIA-PACIFIC MEDICAL MCS DEVICE MARKET SIZE, BY CARDIAC CARE UNITS, 2018-2032 (USD MILLION)
  • TABLE 179. GLOBAL MEDICAL MCS DEVICE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 180. ASEAN MEDICAL MCS DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 181. ASEAN MEDICAL MCS DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 182. ASEAN MEDICAL MCS DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 183. ASEAN MEDICAL MCS DEVICE MARKET SIZE, BY CONTINUOUS FLOW, 2018-2032 (USD MILLION)
  • TABLE 184. ASEAN MEDICAL MCS DEVICE MARKET SIZE, BY MOBILITY, 2018-2032 (USD MILLION)
  • TABLE 185. ASEAN MEDICAL MCS DEVICE MARKET SIZE, BY PORTABLE, 2018-2032 (USD MILLION)
  • TABLE 186. ASEAN MEDICAL MCS DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 187. ASEAN MEDICAL MCS DEVICE MARKET SIZE, BY BRIDGE TO RECOVERY, 2018-2032 (USD MILLION)
  • TABLE 188. ASEAN MEDICAL MCS DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 189. ASEAN MEDICAL MCS DEVICE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 190. ASEAN MEDICAL MCS DEVICE MARKET SIZE, BY CARDIAC CARE UNITS, 2018-2032 (USD MILLION)
  • TABLE 191. GCC MEDICAL MCS DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 192. GCC MEDICAL MCS DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 193. GCC MEDICAL MCS DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 194. GCC MEDICAL MCS DEVICE MARKET SIZE, BY CONTINUOUS FLOW, 2018-2032 (USD MILLION)
  • TABLE 195. GCC MEDICAL MCS DEVICE MARKET SIZE, BY MOBILITY, 2018-2032 (USD MILLION)
  • TABLE 196. GCC MEDICAL MCS DEVICE MARKET SIZE, BY PORTABLE, 2018-2032 (USD MILLION)
  • TABLE 197. GCC MEDICAL MCS DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 198. GCC MEDICAL MCS DEVICE MARKET SIZE, BY BRIDGE TO RECOVERY, 2018-2032 (USD MILLION)
  • TABLE 199. GCC MEDICAL MCS DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 200. GCC MEDICAL MCS DEVICE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 201. GCC MEDICAL MCS DEVICE MARKET SIZE, BY CARDIAC CARE UNITS, 2018-2032 (USD MILLION)
  • TABLE 202. EUROPEAN UNION MEDICAL MCS DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 203. EUROPEAN UNION MEDICAL MCS DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 204. EUROPEAN UNION MEDICAL MCS DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 205. EUROPEAN UNION MEDICAL MCS DEVICE MARKET SIZE, BY CONTINUOUS FLOW, 2018-2032 (USD MILLION)
  • TABLE 206. EUROPEAN UNION MEDICAL MCS DEVICE MARKET SIZE, BY MOBILITY, 2018-2032 (USD MILLION)
  • TABLE 207. EUROPEAN UNION MEDICAL MCS DEVICE MARKET SIZE, BY PORTABLE, 2018-2032 (USD MILLION)
  • TABLE 208. EUROPEAN UNION MEDICAL MCS DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 209. EUROPEAN UNION MEDICAL MCS DEVICE MARKET SIZE, BY BRIDGE TO RECOVERY, 2018-2032 (USD MILLION)
  • TABLE 210. EUROPEAN UNION MEDICAL MCS DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 211. EUROPEAN UNION MEDICAL MCS DEVICE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 212. EUROPEAN UNION MEDICAL MCS DEVICE MARKET SIZE, BY CARDIAC CARE UNITS, 2018-2032 (USD MILLION)
  • TABLE 213. BRICS MEDICAL MCS DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 214. BRICS MEDICAL MCS DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 215. BRICS MEDICAL MCS DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 216. BRICS MEDICAL MCS DEVICE MARKET SIZE, BY CONTINUOUS FLOW, 2018-2032 (USD MILLION)
  • TABLE 217. BRICS MEDICAL MCS DEVICE MARKET SIZE, BY MOBILITY, 2018-2032 (USD MILLION)
  • TABLE 218. BRICS MEDICAL MCS DEVICE MARKET SIZE, BY PORTABLE, 2018-2032 (USD MILLION)
  • TABLE 219. BRICS MEDICAL MCS DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 220. BRICS MEDICAL MCS DEVICE MARKET SIZE, BY BRIDGE TO RECOVERY, 2018-2032 (USD MILLION)
  • TABLE 221. BRICS MEDICAL MCS DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 222. BRICS MEDICAL MCS DEVICE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 223. BRICS MEDICAL MCS DEVICE MARKET SIZE, BY CARDIAC CARE UNITS, 2018-2032 (USD MILLION)
  • TABLE 224. G7 MEDICAL MCS DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 225. G7 MEDICAL MCS DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 226. G7 MEDICAL MCS DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 227. G7 MEDICAL MCS DEVICE MARKET SIZE, BY CONTINUOUS FLOW, 2018-2032 (USD MILLION)
  • TABLE 228. G7 MEDICAL MCS DEVICE MARKET SIZE, BY MOBILITY, 2018-2032 (USD MILLION)
  • TABLE 229. G7 MEDICAL MCS DEVICE MARKET SIZE, BY PORTABLE, 2018-2032 (USD MILLION)
  • TABLE 230. G7 MEDICAL MCS DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 231. G7 MEDICAL MCS DEVICE MARKET SIZE, BY BRIDGE TO RECOVERY, 2018-2032 (USD MILLION)
  • TABLE 232. G7 MEDICAL MCS DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 233. G7 MEDICAL MCS DEVICE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 234. G7 MEDICAL MCS DEVICE MARKET SIZE, BY CARDIAC CARE UNITS, 2018-2032 (USD MILLION)
  • TABLE 235. NATO MEDICAL MCS DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 236. NATO MEDICAL MCS DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 237. NATO MEDICAL MCS DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 238. NATO MEDICAL MCS DEVICE MARKET SIZE, BY CONTINUOUS FLOW, 2018-2032 (USD MILLION)
  • TABLE 239. NATO MEDICAL MCS DEVICE MARKET SIZE, BY MOBILITY, 2018-2032 (USD MILLION)
  • TABLE 240. NATO MEDICAL MCS DEVICE MARKET SIZE, BY PORTABLE, 2018-2032 (USD MILLION)
  • TABLE 241. NATO MEDICAL MCS DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 242. NATO MEDICAL MCS DEVICE MARKET SIZE, BY BRIDGE TO RECOVERY, 2018-2032 (USD MILLION)
  • TABLE 243. NATO MEDICAL MCS DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 244. NATO MEDICAL MCS DEVICE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 245. NATO MEDICAL MCS DEVICE MARKET SIZE, BY CARDIAC CARE UNITS, 2018-2032 (USD MILLION)
  • TABLE 246. GLOBAL MEDICAL MCS DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 247. UNITED STATES MEDICAL MCS DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 248. UNITED STATES MEDICAL MCS DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 249. UNITED STATES MEDICAL MCS DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 250. UNITED STATES MEDICAL MCS DEVICE MARKET SIZE, BY CONTINUOUS FLOW, 2018-2032 (USD MILLION)
  • TABLE 251. UNITED STATES MEDICAL MCS DEVICE MARKET SIZE, BY MOBILITY, 2018-2032 (USD MILLION)
  • TABLE 252. UNITED STATES MEDICAL MCS DEVICE MARKET SIZE, BY PORTABLE, 2018-2032 (USD MILLION)
  • TABLE 253. UNITED STATES MEDICAL MCS DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 254. UNITED STATES MEDICAL MCS DEVICE MARKET SIZE, BY BRIDGE TO RECOVERY, 2018-2032 (USD MILLION)
  • TABLE 255. UNITED STATES MEDICAL MCS DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 256. UNITED STATES MEDICAL MCS DEVICE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 257. UNITED STATES MEDICAL MCS DEVICE MARKET SIZE, BY CARDIAC CARE UNITS, 2018-2032 (USD MILLION)
  • TABLE 258. CHINA MEDICAL MCS DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 259. CHINA MEDICAL MCS DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 260. CHINA MEDICAL MCS DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 261. CHINA MEDICAL MCS DEVICE MARKET SIZE, BY CONTINUOUS FLOW, 2018-2032 (USD MILLION)
  • TABLE 262. CHINA MEDICAL MCS DEVICE MARKET SIZE, BY MOBILITY, 2018-2032 (USD MILLION)
  • TABLE 263. CHINA MEDICAL MCS DEVICE MARKET SIZE, BY PORTABLE, 2018-2032 (USD MILLION)
  • TABLE 264. CHINA MEDICAL MCS DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 265. CHINA MEDICAL MCS DEVICE MARKET SIZE, BY BRIDGE TO RECOVERY, 2018-2032 (USD MILLION)
  • TABLE 266. CHINA MEDICAL MCS DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 267. CHINA MEDICAL MCS DEVICE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 268. CHINA MEDICAL MCS DEVICE MARKET SIZE, BY CARDIAC CARE UNITS, 2018-2032 (USD MILLION)